Regenesis Biomedical Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Wound Therapy System, indicated for the palliative treatment of post-operative pain and edema in superficial soft tissue.
Our customers include health care facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.
People
Dennis Genge (CFO, VP)
Richard A. Isenberg (VP, Clinical and Regulatory Affairs)
Mary C. Ritz (Board Member)
Virginia S. Rybski (CEO, President)
Harry George (Board Member)
View more details about all 6 people at Regenesis Biomedical
Competitors
Advanced BioHealing:
Advanced BioHealing (ABH) was founded in 2003 to develop and commercialize a next-generation bioengineered tissue product.… See Company Profile »
Uromedica:
Adjustable Continence Therapy for Stress Urinary Incontinence Stress incontinence, or the accidental loss of bladder control,… See Company Profile »
Aqueduct Medical:
Founded in 2003, Aqueduct Medical, Inc. is focused on developing safe, effective, user-friendly products that improve… See Company Profile »